Our finding that both HER2 inhibitor-sensitive and -resistant breast cancer cell lines became highly sensitized to THZ1 and exhibited a similar response to THZ1 to that of TNBC, could be attributed to CDK7-dependent transcriptional inhibition[7]. This evidence concerns the gene ERBB2 and breast cancer.